BIOGEN INC. (BIIB) Financials
Annual revenue, profitability and per-share results for BIOGEN INC., as reported in SEC filings.
Revenue · FY2025
$9.89B
▲ 2.2%YoY
Net income · FY2025
$1.29B
▼ 20.8%YoY
Diluted EPS · FY2025
$8.79
▼ 21.4%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $9.89B | $1.29B | — | $8.79 |
| FY2024 | $9.68B | $1.63B | — | $11.18 |
| FY2023 | $9.84B | $1.16B | — | $7.97 |
| FY2022 | $10.17B | $2.96B | — | $20.87 |
Figures as reported in BIOGEN INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a BIIB filing.
Get an email when BIIB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.